AKT1 and non-small cell lung carcinoma: This study suggests that CEP55, previously associated with an unfavorable prognosis in NSCLC patients,54 may drive angiogenesis by activating HIF1α, a crucial transcription factor associated with angiogenesis through the AKT/mTOR signaling pathway.55